AEGLEA BIOTHERAPEUTICS INC
AEGLEA BIOTHERAPEUTICS INC logo
AGLE

AEGLEA BIOTHERAPEUTICS INC (AGLE)

$0.4465.23%

Market is closed
– opens on 8 PM, 07 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$0.420043
Day's Range
$0.4691
$0.372
52-Week Range
$4.83
1 month return64.6%
3 month return10.8%
1 year return87.75%
5 year return90.92%

Company Information

Aeglea BioTherapeutics is a clinical-stage biotechnology company redefining the potential of human enzyme therapeutics to benefit people with rare and devastating metabolic diseases with limited treatment options. Aeglea's lead product candidate, pegzilarginase, is in a pivotal Phase 3 trial for the treatment of Arginase 1 Deficiency and has received both Rare Pediatric Disease and Breakthrough Therapy Designation. In the second quarter of 2020, the Company initiated a Phase 1/2 clinical trial of AGLE-177 for the treatment of Homocystinuria. AGLE-177 has also been granted Rare Pediatric Disease Designation. Aeglea has an active discovery platform focused on engineering small changes in human enzymes to have a big impact on the lives of patients and their families.
OrganizationAEGLEA BIOTHERAPEUTICS INC
Employees69
CEODr. Leslie S. Sloan Ph.D.
IndustryHealth Technology

Analyst Recommendation

based on 7 analysts ratings

Buy
85%
Buy
14%
Hold
0%
Sell

Based on 7 Wall street analysts offering stock ratings for AEGLEA BIOTHERAPEUTICS INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 516.59%

Current

$0.45

Target

$2.75

Recommendation Trend

Based on 7 analyst

Current1M Ago3M Ago
Buy
6
8
9
Hold
1
4
5
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
28.0M
Book Value
$1.1
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-1.09
PEG Ratio
0.0
Wall Street Target Price
2.75

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
0.46
Enterprise Value
-38168310
Enterprise Value/Revenue
1.27
Enterprise Value/Ebitda
0.45

Technicals

Beta
1.74
50 Day MA
0.82
200 Day MA
1.14

Institutional Holdings

Bain Capital Life Sciences Investors, LLC

8.69%

Sio Capital Management, LLC

7.59%

Suvretta Capital Management, LLC

6.6%

Nantahala Capital Management, LLC

6.3%

Rock Springs Capital Management LP

5.55%

Baker Bros Advisors LP

5.54%

Discover more

Frequently Asked Questions

What is AEGLEA BIOTHERAPEUTICS INC share price today?

Can Indians buy AEGLEA BIOTHERAPEUTICS INC shares?

How can I buy AEGLEA BIOTHERAPEUTICS INC shares from India?

Can Fractional shares of AEGLEA BIOTHERAPEUTICS INC be purchased?

What are the documents required to start investing in AEGLEA BIOTHERAPEUTICS INC stocks?

What are today’s High and Low prices of AEGLEA BIOTHERAPEUTICS INC?

What are today’s traded volumes of AEGLEA BIOTHERAPEUTICS INC?

What is today’s market capitalisation of AEGLEA BIOTHERAPEUTICS INC?

What is the 52 Week High and Low Range of AEGLEA BIOTHERAPEUTICS INC?

How much percentage AEGLEA BIOTHERAPEUTICS INC is down from its 52 Week High?

How much percentage AEGLEA BIOTHERAPEUTICS INC is up from its 52 Week low?

What are the historical returns of AEGLEA BIOTHERAPEUTICS INC?

Who is the Chief Executive Officer (CEO) of AEGLEA BIOTHERAPEUTICS INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*